Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.042 AUD | +2.44% | -4.55% | -43.24% |
02-29 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
02-29 | Radiopharm Theranostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.24% | 12.26M | |
+31.92% | 690B | |
+25.63% | 546B | |
-4.61% | 358B | |
+17.58% | 323B | |
+5.55% | 287B | |
+14.28% | 235B | |
+5.49% | 199B | |
-9.82% | 195B | |
+4.37% | 161B |
- Stock Market
- Equities
- RAD Stock
- News Radiopharm Theranostics Limited
- Radiopharm Theranostics, UCLA-TDG Enter Deal to License Cancer-Cell Targeting Antibody